1. Home
  2. ATEC vs WVE Comparison

ATEC vs WVE Comparison

Compare ATEC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$8.28

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.87

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEC
WVE
Founded
1990
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
ATEC
WVE
Price
$8.28
$5.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
16
Target Price
$22.00
$29.81
AVG Volume (30 Days)
2.3M
3.5M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
15.04
N/A
EPS
N/A
N/A
Revenue
$101,739,000.00
$3,704,000.00
Revenue This Year
$18.97
N/A
Revenue Next Year
$16.70
$85.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
149.43
52 Week Low
$6.82
$5.02
52 Week High
$23.29
$21.73

Technical Indicators

Market Signals
Indicator
ATEC
WVE
Relative Strength Index (RSI) 49.25 39.51
Support Level $7.27 $5.02
Resistance Level $8.42 $7.65
Average True Range (ATR) 0.38 0.32
MACD 0.16 0.03
Stochastic Oscillator 90.58 37.34

Price Performance

Historical Comparison
ATEC
WVE

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: